Huakang Biomedical Holdings Company Limited (08622.HK) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 5Aug 10Aug 13Aug 18Aug 21Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−8.3x

Market Cap

HKD 89.38M

MomentumView details →

1D Return

+0.00%

YTD Return

−59.54%

RSI (14)

53.1

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−8.3x

Market Cap

HKD 89.38M

RSI (14)

53.1

MomentumView details →

1D Return

+0.00%

YTD Return

−59.54%

ProfitabilityView details →

Gross Margin

62.37%

Net Margin

−15.96%

EBITDA Margin

−14.14%

ROE (TTM)

−12.53%

ROA (TTM)

−9.29%

Asset Turnover

0.58x

GrowthView details →

Revenue YoY

+50.72%

EPS YoY

−32.97%

FCF YoY

+24.91%

Revenue CAGR 3Y

+3.74%

EPS CAGR 3Y

−16.28%

EBITDA YoY

−56.13%

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.16x

Current Ratio

3.47x

Quick Ratio

3.24x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

38.53M

Net Income (TTM)

−6.15M

Op. CF (TTM)

—

Latest newsMore news →

No recent news for 08622.HK.

Similar companies

AlvotechALVOW InterCure Ltd.INCR Qianhai Health Holdings Limited00911.HK Cumberland Pharmaceuticals Inc.CPIX Procaps Group S.A.PROC BGM Group Ltd.BGM Find similar companies →

Latest newsMore news →

No recent news for 08622.HK.